Viewing nowLadova Tablet 20 mg (Atorvastatin Calcium Hydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
HLB Pharmaceutical Co., Ltd.

MFDS item code 201801735 · Approved 2018.04.24 · Insurance code 647303340
Improvement of hyperlipidemia (including familial hyperlipidemia in children); prevention of cardiovascular diseases (such as myocardial infarction)
This medication helps to reduce the risk of cardiovascular diseases. It particularly decreases the risk of myocardial infarction, stroke, vascular surgery, and stable angina in adult patients with risk factors for coronary heart disease. It also lowers the risk of myocardial infarction and stroke in patients with type 2 diabetes who have cardiovascular risk factors. In patients with coronary heart disease, it reduces the risk of non-fatal myocardial infarction, fatal and non-fatal stroke, vascular surgeries, hospitalizations for congestive heart failure, and angina. Additionally, it is used to lower total cholesterol, LDL cholesterol, apo-B protein, and triglyceride levels while raising HDL cholesterol levels in patients with hyperlipidemia. It is particularly effective in pediatric patients with familial hypercholesterolemia and is beneficial in those with cardiovascular disease risk factors. Thus, this medication is used to improve cardiovascular health and reduce the risk of various related diseases.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This medicine may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start at 20 mg or 40 mg once daily (40 mg only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered at a dose of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, LDL cholesterol levels are recommended for use at the start of treatment and when assessing response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor treatment response. Patients with homozygous familial hypercholesterolemia The dose of this medicine is 10 ~ 80 mg once daily. It is administered in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are unavailable. ○ Patients with renal impairment: Renal disease does not affect atorvastatin plasma concentrations or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are generally similar to those in the usual adult patient population.
Pediatric patients (10 ~ 17 years) with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily, and the recommended maximum dose is 20 mg once daily (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted as appropriate according to the recommended treatment goal for each patient. Dose adjustments should be made at intervals of 4 weeks or longer.
This medication may cause muscle abnormalities; if symptoms such as muscle pain or weakness worsen, you should inform your doctor immediately. Particularly, if muscle enzyme levels rise significantly or if myopathy is suspected, drug administration should be discontinued. Patients with poor liver function or liver diseases should not use this drug, or should do so cautiously. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. It should not be administered to children under 10 years of age. Consultation with a doctor or pharmacist is necessary when combining this drug with other specific medications, as the risk of muscle damage may increase. Caution is necessary for patients with a history of alcohol abuse or liver disease when taking this medication. Regular liver function tests are required as this medication may produce side effects such as liver dysfunction, hepatitis, and jaundice. If symptoms such as muscle pain, fatigue, or fever occur, consult a doctor immediately. Care should be taken when taking this medication along with grapefruit juice or certain antibiotics and antifungals, as this can increase drug concentration and the risk of side effects. Proper contraceptive methods should be used during treatment, and if pregnancy is confirmed, administration should be stopped. Particular caution is required for children, the elderly, and patients with renal dysfunction, as they have a higher risk of developing myopathy when using this medication. There are no specific detoxification methods for overdose; it is important to receive treatment based on symptoms. The medication should be stored out of the reach of children and kept in its original container.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. It is recommended to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. This will help preserve the efficacy of the medication for a longer period.
White round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAtorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
HLB Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.